Jove
Visualize
Contact Us

Related Experiment Videos

Gene transfer in experimental medicine.

Gaetano Romano1

  • 1Department of Neurosurgery, The Farber Institute for the Neurosciences, Jefferson Medical College, Thomas Jefferson University, Jefferson Hospital for the Neurosciences, 900 Walnut Street Suite 422, Philadelphia, PA 19107, USA. Gaetano.Romano@jefferson.edu

Drug News & Perspectives
|August 28, 2003
PubMed
Summary

Gene transfer technology shows promise for treating various diseases, including cancer and neurodegenerative conditions. Advances in vector design are crucial for improving gene delivery, expression, and safety in clinical applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[<sup>18</sup>F]FDG PET/CT Radiomics for Predicting Pathological Risk Subtypes of Thymic Epithelial Tumors: A Bicentric Study.

Cancers·2026
Same author

Comparative Effectiveness of Physical and Virtual Reality Simulators in Robotic Surgical Training.

Journal of clinical medicine·2026
Same author

Long-term effectiveness of thymectomy in late-onset myasthenia gravis.

Journal of neurology·2025
Same author

Surgical Management of Pulmonary Typical Carcinoids: A Single-Centre Experience Comparing Anatomical and Non-Anatomical Resections.

Journal of clinical medicine·2025
Same author

Long-Term Oncological Outcomes Related to Lymphadenectomy in Clinical Stage I NSCLC: A Multicenter Retrospective Experience.

Current oncology (Toronto, Ont.)·2025
Same author

Access of migrant women to sexual and reproductive health services: A systematic review.

Midwifery·2024
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • * Medical Genetics
  • * Molecular Biology
  • * Translational Medicine

Background:

  • * Gene transfer technology offers potential therapeutic applications across diverse medical fields.
  • * Clinical trials (Phase I and II) are underway for cancers, genetic disorders, neurodegenerative diseases, cardiopathies, and infectious diseases.
  • * Emerging gene therapy approaches target Parkinson's, Alzheimer's, Huntington's disease, ALS, spinal cord injury, and diabetes.

Purpose of the Study:

  • * To review the latest advancements and challenges in gene therapy clinical trials and preclinical studies.
  • * To highlight the critical role of vector design in enhancing gene delivery, transgene expression, and safety.
  • * To assess the current status and future directions of gene transfer technology in medicine.

Main Methods:

Related Experiment Videos

  • * Comprehensive literature review of published clinical trials and preclinical research.
  • * Analysis of gene transfer vector design strategies and their impact on therapeutic outcomes.
  • * Synthesis of data on the efficacy and safety of gene-based interventions.

Main Results:

  • * Significant progress has been made in vector design, yielding encouraging results in both clinical and preclinical settings.
  • * Gene therapy is being actively investigated for a wide range of conditions, with some trials showing promise.
  • * Current vector designs require further development to ensure efficient and safe gene-based therapeutic interventions.

Conclusions:

  • * Gene transfer technology holds substantial therapeutic potential, supported by ongoing clinical trials and research.
  • * Vector design improvements are essential for overcoming current limitations and enabling widespread clinical success.
  • * Continued research and development in vector technology are critical for realizing the full potential of gene therapy.